Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-26

Clinical Trial Update: Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the four-drug chemotherapy regimen of gemcitabine, cisplatin, 5-fluorouracil, and folinic acid in esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adrucil (5-fluorouracil)
  • Gemzar (gemcitabine)
  • Platinol (cisplatin)
  • Wellcovorin (leucovorin calcium)

Snippet

Sponsor: CONKO-Studiengruppe | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED